Yıl: 2020 Cilt: 11 Sayı: 1 Sayfa Aralığı: 100 - 106 Metin Dili: Türkçe DOI: 10.22312/sdusbed.602903 İndeks Tarihi: 07-05-2021

L-Karnitin Depresyon Üzerinde Etkili Midir?

Öz:
Karnitin hem endojen biyosentez yoluyla vücuttasentezlenmekte hem de günlük diyetle besinlerdenalınmaktadır. Karnitin (trimetilamino-β-hidroksibutirat),hücre ve dokularda, açil-L-karnitin dahil olmak üzere hemserbest karnitin hem de açilkarnitinler olarak bulunmaktadır.Karnitin uzun zincirli yağ asitlerinin β-oksidasyonu içinmitokondriye taşıyıcı olarak görev yapmaktadır. Karnitinkarboksilik asitler ile ester oluşturma yeteneğinden dolayıdiğer metabolitlerin taşınmasında da önem taşımaktadır.Ayrıca karnitin nörotransmitterlerin aktivitesini modüle edereksinir sisteminde önemli rol oynamaktadır. Depresyon yaşamkalitesinin büyük ölçüde azalması, eşlik eden hastalıklarınartması ve artmış ölüm oranı ile ilişkili bir bozukluktur.Depresyonlu bireylerde yağ asitleri ve lipit metabolizmasıdeğişikliklerinin oluştuğu bildirilmiştir. Bu nedenle karnitinin,sinir dokularındaki çeşitli nörotrofik faktörlerin, hücrezarlarının, lipid metabolizmasının ve nörotransmitterlerinaktivitesini modüle ettiği düşünüldüğünde, depresyontedavisinde karnitin takviyesinin antidepresanlara alternatiftedavi edici ajan olarak potansiyel bir rolü olduğu ilerisürülmüştür. Karnitin beyinde yaygın olarak bulunmakta vekolinerjik reseptörler üzerinde uyarıcı etki göstermektedir.Ayrıca karnitin nöromodülatör etki göstererek dopaminsalınımının artmasını ve gama-aminobutirik asidin artmasınısağlamaktadır. Karnitin sinir sisteminde antioksidan venörotrofik etki göstermektedir. Hayvan ve insan modelli klinikçalışmalarda depresyon üzerinde karnitinin olumlu etkilerininolduğu belirlenmiştir. L-karnitinin antidepresan ilaçlar ilebenzer etki gösterdiği ve yan etkilerinin daha düşük olduğuçalışmalarla gösterilmiştir. Karnitin takviyesinin antidepresanve nörotrofik etkilerinden dolayı depresyon tedavisinde etkinrolü olabileceği düşünülmektedir.
Anahtar Kelime:

Is L-Carnitine Effective on Depression?

Öz:
Carnitine is synthesized both by endogenous biosynthesis in the body and is taken from foods with daily diet. Carnitine (trimethyl amino-β-hydroxybutyrate) is present in cells and tissues as both free carnitine and acylcarnitins, including acetyl-L-carnitine. Carnitine acts as a carrier of mitochondria for the β-oxidation of long chain fatty acids. Carnitine is also important in the transport of other metabolites due to its ability to form esters with carboxylic acids. Carnitine also plays a role in the nervous system by modulating the activity of neurotransmitters. Depression is a disorder associated with a significant decrease in quality of life, increased physical comorbidities, and increased mortality. It is thought that changes in fatty acids and lipid metabolism occur in individuals with depression. Therefore, when carnitine is thought to modulate the activity of various neurotrophic factors, cell membranes, lipid metabolism and neurotransmitters in nerve tissues, carnitine supplementation has been suggested to have a potential role as an alternative therapeutic agent to antidepressants. Carnitine is common in the brain and has a stimulating effect on cholinergic receptors. In addition, carnitine exhibits neuromodulatory effect and increases dopamine release and increases gamma-aminobutyric acid. Carnitine has antioxidant and neurotrophic effects in nervous system. Animal and human model clinical studies have shown positive effects of carnitine on depression. Studies have shown that L-carnitine has similar effects with antidepressant drugs and has lower side effects. It is thought that carnitine supplementation may have an effective role in the treatment of depression due to its antidepressant and neurotrophic effects.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Wang SM, Han C, Lee SJ, Patkar A, Masand PS, Pae CU. A review of current evidence for acetyl-L-carnitine in the treatment of depression. Journal of Psychiatric Research 2014; 53: 30-7.
  • 2. Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosomatic Medicine 2018; 80(2): 154-59.
  • 3. Nasca C, Bigioa B, Leec FS, Younge SP, Kautzg MM, Albrightd A, et al. Acetyl-L-carnitine deficiency in patients with major depressive disorder. PNAS 2018; 115(34): 8627- 32.
  • 4. Machado-Vieira R, Salvadore G, Luckenbaugh DA, Manji HK, Zarate Jr CA. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depression. The Journal of clinical psychiatry 2008; 69(6): 946-958.
  • 5. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43(5): 315–19.
  • 6. Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Prog Lipid Res 2010; 49(1): 61–75.
  • 7. Ferreira GC, McKenna MC. L-Carnitine and acetyl-Lcarnitine roles and neuroprotection in developing brain. Neurochem Res. 2017; 42(6): 1661–75.
  • 8. Sergi G, Pizzato S, Piovesan F, Trevisan C, Veronese N, Manzato E. Effects of acetyl-lcarnitine in diabetic neuropathy and other geriatric disorders. Aging Clin Exp Res 2018; 30(2): 133–38.
  • 9. Traina G. The neurobiology of acetyl-L-carnitine. Frontiers in Bioscience (Landmark Ed) 2016; 21: 1314-29.
  • 10. Ando S, Tadenuma T, Tanaka Y, Fukui F, Kobayashi S, Ohashi Y, et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res 2001; 66(2): 266-271.
  • 11. Janiri L, Falcone M, Persico A, E Tempesta. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J Neural Transm Gen Sect 1991; 86(2): 135-146.
  • 12. Robinson BL, Dumas M, Cuevas E, Gu Q, Paule MG, Ali SF, et al. Distinct effects of ketamine and acetyl l-carnitine on the dopamine system in zebrafish. Neurotoxicology and teratology 2016; 54:52-60.
  • 13. Wu C, Gopal KV, Moore EJ, Gross GW. Antioxidants L-carnitine and D-methionine modulate neuronal activity through GABAergic inhibition. Journal of neural transmission 2014; 121(7): 683-693.
  • 14. Zaitone SA, Abo-Elmatty DM, Shaalan AA. Acetyl-Lcarnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy. Pharmacology Biochemistry and Behavior 2012; 100(3): 347-360.
  • 15. Scafidi S, Fiskum G, Lindauer SL, Bamford P, Shi D, Hopkins I, et al. Metabolism of acetyl‐L‐carnitine for energy and neurotransmitter synthesis in the immature rat brain. Journal of neurochemistry 2010; 114(3): 820-831.
  • 16. Onofrj M, Ciccocioppo F, Varanese S, Di Muzio A, Calvani M, Chiechio S, et al. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert review of neurotherapeutics 2013; 13(8): 925-936.
  • 17. Smeland OB, Meisingset TW, Borges K, Sonnewald U. Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochemistry international 2012; 61(1): 100-7.
  • 18. Bavari M, Tabandeh MR, Najafzadeh Varzi H, Bahramzadeh S. Neuroprotective, antiapoptotic and antioxidant effects of l-carnitine against caffeine-induced neurotoxicity in SH-SY5Y neuroblastoma cell line. Drug and chemical toxicology 2016; 39(2): 157-166.
  • 19. Kanter M, Topcu-Tarladacalisir Y, Parlar S. Antiapoptotic effect of L-carnitine on testicular irradiation in rats. Journal of molecular histology 2010; 41(2-3): 121-128.
  • 20. Moretti S, Famularo G, Marcellini S, Boschini A, Santini G, Trinchieri V, et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxidants and Redox Signaling 2002; 4(3): 391-403.
  • 21. Post RM. Myriad of implications of acetyl-L-carnitine deficits in depression. PNAS 2018; 115(34): 8475–77.
  • 22. Peedicayil J. L-Acetylcarnitine as a histone acetylation modulator in psychiatric disorders. Psychopharmacology 2018; 235(11): 3361–62.
  • 23. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proceedings of the National Academy of Sciences of the United States of America 2013; 110(12): 4804-09.
  • 24. Matrisciano F, Caruso A, Orlando R, Marchiafava M, Bruno V, Battaglia G, et al. Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology 2008; 55(4): 525-31.
  • 25. Cuccurazzu B, Bortolotto V, Valente MM, Ubezio F, Koverech A, Canonico PL, et al. Upregulation of mGlu2 receptors via NF-kappaB p65 acetylation is involved in the proneurogenic and antidepressant effects of acetyl-Lcarnitine. Neuropsychopharmacology 2013; 38(11): 2220-30.
  • 26. Sima AAF, Ristic H, Merry A, Kamijo M, Lattimer SA, Stevens MJ, et al. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J Clin Invest 1996; 97(8): 1900–07.
  • 27. Bigini P, Larini S, Pasquali C, Muzio V, Mennini T. Acetyl- L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. Neurosci Lett 2002; 329(3): 334–38.
  • 28. Silva Adaya D, Pérez De La Cruz V, Herrera Mundo MN, Mendoza Macedo K, Villeda Hernández J, Binienda Z, et al. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of l‐carnitine. Journal of neurochemistry 2008; 105(3): 677-89.
  • 29. Karalija A, Novikova LN, Kingham PJ, Wiberg M, Novikov LN. Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. PLoS One 2012; 7(7): e41086.
  • 30. Ferrari F, Gorini A, Villa RF. Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: Effect of L-acetylcarnitine and relationships with Dementia and Depression pathophysiology. European Journal of Pharmacology 2015; 756: 67–74.
  • 31. Levine J, Kaplan Z, Pettegrew JW, McClure RJ, Gershon S, Buriakovsky I, et al. Effect of intraperitoneal acetyl- L-carnitine (ALCAR) on anxiety-like behaviours in rats. International Journal of Neuropsychopharmacology 2005; 8(1): 65-74.
  • 32. Wang W, Lu Y, Xue Z, Li Z, Wang C, Zhao X, et al. Rapidacting Antidepressant-like Effects Of Acetyl-l-carnitine Mediated By PI3K/AKT/BDNF/VGF Signaling Pathway In Mice. Neuroscience 2015; 285: 281–91.
  • 33. Mannelli LDC, Vivoli E, Salvicchi A, Schiavone N, Koverech A, Messano M, et al. Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression. Psychopharmacology 2011; 218(2): 347-56.
  • 34. Tashiro K, Kaida Y, Yamagishi S, Tanaka H, Yokoro M, Yano J, et al. L-carnitine Supplementation Improves Selfrating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis. Letters in Drug Design & Discovery 2017; 14(6): 737-42.
  • 35. Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, et al. Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2011; 46(6): 750–59.
  • 36. Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope Jr HG, et al. A Placebo-Controlled Trial of Acetyl- L-Carnitine and α-Lipoic Acid in the Treatment of Bipolar Depression. J Clin Psychopharmacol. 2013; 33(5): 627–35.
  • 37. Fukami K, Yamagishi S, Sakai K, Kaida Y, Minami A, Nakayama Y, et al. Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis. Aging Male, 2014; 17(4): 238–42.
  • 38. Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression. J Acquir Immune Defic Syndr 2015; 69(1): 18–28.
  • 39. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 2004; 63(4): 641-6.
  • 40. Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Shaiova L, et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: A preliminary analysis. Annals of the New York Academy of Sciences 2004; 1033(1): 168-76.
  • 41. Jamilian H, Jamilian M, Samimi M, Afshar Ebrahimi F, Rahimi M, Bahmani F, et al. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecological Endocrinology 2017; 33(6): 442-7.
  • 42. Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl- L -carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol 2006; 16(4): 281 -7.
  • 43. Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, et al. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011; 35(4): 953-8.
  • 44. Rezaee H, Khalili H, Hatamkhani S, Dashti-Khavidaki S, Khazaeipour Z. Frequency of depression and its correlation with serum carnitine level in HIV/AIDS patients. Curr HIV Res. 2013; 11(3): 226-30
APA tekin t, Ayaz A (2020). L-Karnitin Depresyon Üzerinde Etkili Midir?. , 100 - 106. 10.22312/sdusbed.602903
Chicago tekin tuba,Ayaz Aylin L-Karnitin Depresyon Üzerinde Etkili Midir?. (2020): 100 - 106. 10.22312/sdusbed.602903
MLA tekin tuba,Ayaz Aylin L-Karnitin Depresyon Üzerinde Etkili Midir?. , 2020, ss.100 - 106. 10.22312/sdusbed.602903
AMA tekin t,Ayaz A L-Karnitin Depresyon Üzerinde Etkili Midir?. . 2020; 100 - 106. 10.22312/sdusbed.602903
Vancouver tekin t,Ayaz A L-Karnitin Depresyon Üzerinde Etkili Midir?. . 2020; 100 - 106. 10.22312/sdusbed.602903
IEEE tekin t,Ayaz A "L-Karnitin Depresyon Üzerinde Etkili Midir?." , ss.100 - 106, 2020. 10.22312/sdusbed.602903
ISNAD tekin, tuba - Ayaz, Aylin. "L-Karnitin Depresyon Üzerinde Etkili Midir?". (2020), 100-106. https://doi.org/10.22312/sdusbed.602903
APA tekin t, Ayaz A (2020). L-Karnitin Depresyon Üzerinde Etkili Midir?. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, 11(1), 100 - 106. 10.22312/sdusbed.602903
Chicago tekin tuba,Ayaz Aylin L-Karnitin Depresyon Üzerinde Etkili Midir?. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 11, no.1 (2020): 100 - 106. 10.22312/sdusbed.602903
MLA tekin tuba,Ayaz Aylin L-Karnitin Depresyon Üzerinde Etkili Midir?. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, vol.11, no.1, 2020, ss.100 - 106. 10.22312/sdusbed.602903
AMA tekin t,Ayaz A L-Karnitin Depresyon Üzerinde Etkili Midir?. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi. 2020; 11(1): 100 - 106. 10.22312/sdusbed.602903
Vancouver tekin t,Ayaz A L-Karnitin Depresyon Üzerinde Etkili Midir?. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi. 2020; 11(1): 100 - 106. 10.22312/sdusbed.602903
IEEE tekin t,Ayaz A "L-Karnitin Depresyon Üzerinde Etkili Midir?." Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, 11, ss.100 - 106, 2020. 10.22312/sdusbed.602903
ISNAD tekin, tuba - Ayaz, Aylin. "L-Karnitin Depresyon Üzerinde Etkili Midir?". Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 11/1 (2020), 100-106. https://doi.org/10.22312/sdusbed.602903